We found an unfavorable association between improved clinical outcomes in ICI-treated NSCLC and an elevated density of CXCL13+ cells in non-TLS regions, including the tumor, non-tumor, and invasive margin, as well as solely the NT (T+NT+IM, NT). The gene discussed is CXCL13; the disease is neoplasm.